VAXCHORA® - Now Registered
VAXCHORA® is indicated for active immunisation against disease caused by Vibrio cholerae serogroup O1 in adults and children aged 2 years...
top of page
Search
- Feb 20, 2023
IMOJEV® - Japanese encephalitis vaccine, live attenuated
As of February 17 2023, Biocelect Pty Ltd is proud to have added IMOJEV (Japanese encephalitis vaccine, live attenuated) to our portfolio...
- Jun 15, 2022
Bringing Novavax to Australia’s COVID-19 vaccine rollout
Biocelect is proud to partner with NSW Health and NOVAVAX INC on clinical trials and making new vaccines available for all Australians
- May 3, 2021
MedTwos: Jenny and Karl Herz
A great profile on our company Founders, Owners and Managing Directors; Karl Herz and Jennifer Herz, who met in 1991. Discussing their...
- Jan 22, 2021
Biocelect announced as Sponsor for Australia and New Zealand for Novavax COVID-19 vaccine
Biocelect is proud to support Novavax as Sponsor for their COVID-19 vaccine candidate NVX-CoV2373 and assist with roll-out in Australia...
- Dec 18, 2020
Rapivab
Biocelect is excited to announce its partnership with BioCryst Pharmaceuticals Inc. As a result Biocelect is now the exclusive...
- Dec 18, 2020
New Point of Care COVID-19 Antigen Test Approved
Biocelect announces it's partnership with Korean company SD Biosensor for the TGA approved Standard Q COVID-19 Antigen Test. The test is...
- Jul 15, 2020
Tafenoquine inhibits replication of SARS-Cov-2 at pharmacologically relevant concentrations in vitro
60 Degrees Pharmaceuticals Announces Positive Results of Cell Culture Testing of ARAKODA (tafenoquine) for COVID-19 Find full press...
- Apr 7, 2020
Vivotif
Biocelect is proud to announce its partnership with Emergent Travel Health (Emergent Biosolutions). As a result Biocelect is now the...
- Nov 30, 2019
Perth Healthed GP Education Day
Biocelect attends the Perth Healthed GP Education Day in November 2019. Final leg of the Healthed GP Education National tour completed....
- Oct 30, 2019
Biocelect attends the 2019 AMMA Conference in Adelaide
The Biocelect team was pleased to attend and exhibit at the Australian Military Medical Association (AMMA) 2019 Conference "after the WAR...
- Oct 15, 2019
Melbourne and Brisbane Healthed GP Education Days
Two more successful trips for the Biocelect team at the Healthed General Practice Day Conferences taking place across the country this...
- Sep 15, 2019
Adelaide Healthed GP Education Day
Biocelect attends the Adelaide Healthed GP Education Day Saturday 14th September 2019 at the Adelaide Convention Centre. Great day for...
- Sep 10, 2019
Southern Cross Travel Medicine Conference (SCTMC 2019)
Members from the Biocelect team attend the 4th Annual Southern Cross Travel Medicine Conference(SCTMC 2019) in Sydney (hosted by...
- Aug 25, 2019
Sydney Healthed GP Education Day
Biocelect attends the Sydney Healthed GP Education Day Saturday 24th August 2019 at Darling Harbour. An interesting, informative and busy...
- Mar 19, 2019
Kodatef Available in Australia
60 Degrees Pharmaceuticals (60P) and its Australian distribution partner Biocelect Pty Ltd, began commercialising the new malaria...
- Sep 18, 2018
TGA Approves Kodatef
Biocelect welcomes Australia's Therapeutic Goods Administration (TGA) approval of KODATEF (tafenoquine); the first malaria prevention...
- Jul 25, 2018
FDA Votes in Favour of Arakoda
US FDA Advisory Committee votes in favour of 60 Degrees Pharmaceuticals (60P) ARAKODA (tafenoquine) for the prevention of malaria
- Jul 19, 2018
Krintafel (tafenoquine) Approved for Radical Cure in USA
US FDA approves Krintafel (tafenoquine) for the radical cure of P. vivax malaria
bottom of page